Haemoglobin and non-alcoholic fatty liver disease: Further evidence from a population-based study

Gut

Volumn 58, Issue 12, 2009, Pages 1706-1707

  Xu, L ^a,b   Xu, C F ^b   Yu, C H ^b   Miao, M ^c   Li, Y M ^b  

^a NINGBO FIRST HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c SINOPEC Zhenhai Refining & Chemical Company   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN;

FATTY LIVER; HUMAN; LETTER; LIVER INJURY; NON ALCOHOLIC FATTY LIVER DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED;

EID: 72549099600     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.186668     Document Type: Letter

References (5)

1. Trak-Smayra V, Dargere D, Noun R, et al. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery. Gut 2009;58:825-832
2. Li Y, Xu C, Yu C, et al. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009;50:1029-1034
3. Marchesini G, Avagnina S, Barantani EG, et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest 2005;28:333-339 (Pubitemid 43162752)
4. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006;101:76-82.
5. Chang Y, Ryu S, Sung E, et al. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 2007;53:686-692 (Pubitemid 46580239)